Market News 10 min read

UK Market Breakdown: Banks Lead, Pill Cools Hikes, Week of 12 October 2026

The FTSE 100 hit a three-week high after the Bank of England's Huw Pill questioned market bets on four rate rises. Banks led Monday's rally, while London Stock Exchange Group slid on a $3.5bn deal.

A kettle just lifted off the flame, steam swirling as the spout points upward

London's interest rate debate set the tone for the week so far. Going into Monday, money markets had moved to price a quarter-point rise in Bank Rate at the Bank of England's 5 November meeting as the clear favourite — put at roughly an 88% chance as at 13 October on one market reading — along with four quarter-point increases over the coming year. On Wednesday, one of the Monetary Policy Committee's own hawks pushed back.

Huw Pill, the Bank's chief economist, told a Citi event on the sidelines of the IMF annual meetings in Bangkok that he was more sceptical about market pricing of four 25 basis-point hikes. Coming from a man who voted to raise Bank Rate to 4% in September, the remark carried weight. The FTSE 100 finished Wednesday up 74.53 points, or 0.7%, at 10,724.86 — its highest close in three weeks — despite US inflation having landed hotter than forecast earlier the same day.

Measured from Friday 9 October's close of 10,552.05, the blue-chip index is up 172.81 points, or 1.6%, across the week's first three completed sessions. The FTSE 250 has added 0.6%.

The FTSE 100

Monday did the heavy lifting. The index closed up 0.99% at 10,656.28, finishing at its session high and outperforming every other major European market. Lloyds, HSBC, Standard Chartered, NatWest and Barclays all advanced as investors positioned for the start of the US bank reporting season. Energy helped too: Brent crude rose 1.8% to $106.60 a barrel and West Texas Intermediate gained 1.9% to $93.57, after a weekend Houthi attack on a Saudi airport and a Ukrainian claim that Russia had violated an energy ceasefire.

Tuesday gave almost none of it back but added nothing either. The FTSE 100 slipped 5.95 points, or 0.06%, to 10,650.33, having traded as high as 10,762.01 intraday before fading. Worries about artificial intelligence valuations weighed on chip-exposed names globally, and strong US bank results were not enough to offset that. Trading Economics listed Antofagasta, London Stock Exchange Group and Rolls-Royce among the day's heaviest decliners.

Wednesday's gain came in two parts: Pill's remarks in the morning, then a resilient afternoon after US CPI printed at 3.7% year on year against a 3.6% forecast. Healthcare and housebuilders led. AstraZeneca rose 404p to 12,300p, a gain of 3.4%, and GSK added 63p to 1,816p, up 3.6%. Barratt Redrow was the top riser in percentage terms, up 11.8p to 304.1p, or 4%. Burberry gained 36.5p to 1,074p and Babcock International rose 26.2p to 913.4p.

Precious-metal miners were the clear laggards. Fresnillo was the biggest FTSE 100 faller, down 126p to 2,590p — a drop of 4.6% — as gold slid about 1.3% to around $4,105 an ounce and silver tumbled roughly 6% to $55.63, both hit by the stronger dollar and firmer US rate expectations that followed the inflation print. Endeavour Mining fell 141p to 3,991p.

The FTSE 250 and mid caps

The mid-cap index has been the quieter of the two. From 24,213.80 on 9 October, the FTSE 250 closed Monday at 24,328.06 (up 0.47%), Tuesday at 24,339.19 and Wednesday at 24,360.77, a gain of 21.58 points or 0.1%. That is 0.6% for the week so far — less than the FTSE 100, a reversal of the pattern seen a fortnight earlier.

Individual results did far more than the index level suggests: Marston's, Robert Walters and Softcat all moved sharply on their own numbers.

Further down the market, the AIM All-Share closed Tuesday at 768.48, down almost three points, having lost 0.8% over the preceding week as higher bond yields pressed on smaller companies. Lexington Gold gained around 9% after winning appeals to renew prospecting rights in South Africa, while Helium One fell about 22%; the company announced a £3m fundraise on Wednesday to help fund its Colorado project.

The week's biggest movers

CompanyMoveWhy
Marston's (MARS.L)+18% to 54.6p (Tue)Full-year profit guided above the top of expectations
Hays (HAS.L)−9% to −12% (Mon)14th straight quarterly fee decline
Robert Walters (RWA.L)+8% (Wed)Return to fee growth, UK net fees up 10%
Softcat (SCT.L)−6% to −8% (Wed)Record FY26 profit but slower FY27 guidance
Melrose Industries (MRO.L)+4% (Tue)GKN Aerospace settled a California case
London Stock Exchange Group (LSEG.L)−4.7% to −5.7% (Tue)Confirmed talks over a $3.5bn acquisition
Fresnillo (FRES.L)−4.6% to 2,590p (Wed)Gold below $4,100, silver down about 6%
Barratt Redrow (BTRW.L)+4% to 304.1p (Wed)Rate-rise expectations cooled after Pill's remarks

Hays had the week's roughest session. The recruiter's shares fell sharply on Monday — one report put the decline at 12% at its worst before settling near 9% — even though the first-quarter numbers beat expectations. Like-for-like net fees fell 3% in the three months to 30 September against a 4% consensus decline, but it was the 14th consecutive quarterly fall. Permanent fees dropped 7%, with placements down 12%, while temporary and contracting fees fell just 1%.

Melrose Industries topped the FTSE 100 on Tuesday after its GKN Aerospace unit reached a $125m settlement with California authorities over a chemical incident at its Garden Grove site in May.

Marston's gain was the largest in the mid-caps. Like-for-like sales fell 1.2% across the full year, improving to broadly flat in the fourth quarter, and recurring free cash flow took leverage to roughly 4.2 times EBITDA — about half the fiscal 2023 level. The board said it intends to announce a shareholder return programme, likely buybacks, at its preliminary results on 24 November.

Softcat fell despite what it called another year of exceptional growth. Underlying operating profit for the year to 31 July rose 19.4% to £215.1m, with statutory operating profit of £196.4m after £18.7m of excluded costs. What unsettled the market was guidance for high single-digit underlying operating profit growth in FY27, excluding the US GDT business it has agreed to buy.

Company news in focus

The week's biggest corporate story was London Stock Exchange Group. On Tuesday it confirmed talks over a possible acquisition of Octus, a credit-data business controlled by private equity firm Permira, in a deal reported at about $3.5bn. LSEG said no agreement had been reached and that any transaction would need regulatory approval, arguing it would fit its fixed-income and private-markets franchises and add to revenue growth immediately. The statement did not address funding, earnings impact or Octus's revenue, and the shares fell between 4.7% and 5.7% depending on the source.

Balfour Beatty agreed to sell its 50% stake in Gammon Construction to joint-venture partner Jardine Matheson for £250m in cash. The shares eased around 2.2% — among the group's first sessions back in the FTSE 100, which it rejoined on 1 October after a 17-year absence.

Kingfisher named Sebastian Gundel, formerly chief executive of German chain OBI, as its next chief executive from 1 February 2027, succeeding Thierry Garnier. The announcement came with no change to guidance, and the shares rose modestly. Chemring gained after saying its Roke subsidiary had signed a multi-year strategic partnering agreement with a major US prime contractor worth at least $170m over its first five years.

Takeover activity continued to thin out the London market. Shareholders in Gamma Communications vote on 20 October on Epiris's cash offer of 1,120p a share — a 53% premium to the 732p close on 7 April, valuing the equity at about £1.02bn — which the board unanimously recommends. Aberdeen Investments warned of UK "takeover fatigue" ahead of the vote and Peel Hunt's weekly tally put the value of ongoing UK bids at £74.2bn so far in 2026. On the broker front, Barclays upgraded NatWest to overweight and lifted its target price to 850p from 740p.

Earnings and trading updates

BP delivered the most striking set of numbers. Its third-quarter trading statement on Tuesday put the refining indicator margin at $46.70 a barrel, against $29.60 in the second quarter and $15.80 a year earlier, and guided to a $1.9bn to $2.1bn uplift in the products segment versus the previous quarter. BP also estimated net debt of $13.5bn to $14.5bn at the end of September, down from $22.3bn at the end of June, alongside $3bn to $4.5bn of impairments in its gas and low-carbon energy segment. The shares rose about 1.4%.

Rio Tinto published third-quarter production results on Wednesday. Global iron ore sales rose 3% year on year to 90.8 million tonnes, with Pilbara shipments up 2% at 85.7 million tonnes. The Simandou project in Guinea reached an annualised run-rate of about 10 million tonnes a year and remains on track for 60 million tonnes during the second half of 2028. Copper held up on the strength of Oyu Tolgoi in Mongolia, where third-quarter output of 114,000 tonnes was 27% higher year on year.

Whitbread reported first-half adjusted pre-tax profit down 9% at £287m on revenue up 2% at about £1.57bn, ahead of forecasts. Statutory pre-tax profit fell 62%, largely on non-cash impairments, and the interim dividend was held at 36.4p. The Premier Inn owner kept its full-year outlook and used the results to urge shareholders to reject activist Corvex's demand for a board seat; Corvex, which holds about 6.4% of the shares, has nominated its partner James Gemmel. A general meeting is set for 9 November.

PageGroup reported third-quarter gross profit of £190.5m, up 1.5% on a year earlier and its first growth since the fourth quarter of 2022, though UK gross profit fell 5.5% to £21.4m. Ashmore said assets under management edged $500m higher to $54.5bn in its first quarter, with $1.1bn of net inflows more than offsetting $600m of negative investment performance. Greencore upgraded its FY26 adjusted operating profit guidance again, citing volume growth ahead of the market and progress integrating Bakkavor; the shares were little changed at 262.80p.

Macro and the Bank of England

Bank Rate stands at 3.75%, held for a sixth consecutive meeting in September on a 6-3 vote, with Megan Greene, Catherine Mann and Huw Pill in the minority favouring a rise to 4%. That makes Pill's Wednesday scepticism notable: the pushback came from the hawkish wing, not the doves. The next decision is due on 5 November alongside the Monetary Policy Report.

Gilts remain the pressure point. The 10-year yield was around 5.44% and the 30-year around 5.91% on 13 October, having peaked at 6.036% on 7 October — the highest since January 1998. Those levels matter for Chancellor John Healey's Budget on 28 October, with rising yields having eaten into his fiscal headroom.

The IMF's World Economic Outlook, released in Bangkok on Tuesday, raised its 2026 UK growth forecast to 1.3% from 1.0% in July, crediting AI-related investment and exports. It trimmed 2027 to 1.2% and projected UK inflation at 3.3% this year. UK CPI was last reported at 3.1% for August.

In currencies, sterling firmed slightly to about $1.326 on Wednesday and the euro touched a fresh 16-month low against the pound. US CPI at 3.7% left traders pricing roughly even odds on a Federal Reserve rise at the 27-28 October meeting — the read-across that knocked gold, silver and the London-listed miners that track them.

Still to come

DateEvent
Thu 15 OctONS monthly GDP for August; Dunelm first-quarter trading update
Mon 20 OctONS labour market overview; Gamma Communications vote on the Epiris offer
Wed 21 OctUK CPI for September, plus producer price inflation
Thu 22 OctBarclays third-quarter results; London Stock Exchange Group third-quarter update
Fri 23 OctONS retail sales for September
Wed 28 OctAutumn Budget
Thu 29 OctLloyds third-quarter statement; Computacenter third-quarter update
Fri 30 OctBP third-quarter results; ONS Blue Book 2026 revisions

Thursday's GDP release is the first to carry the annual Blue Book revisions across the whole time series, so past months are open to larger-than-usual changes.

This article is for information and education only. It is not financial advice or a recommendation to buy, sell or hold any investment. Always do your own research.

Was this useful?
Sign in to vote
4 of 4
Compare LLOY, HSBA, STAN, NWG